Key Points :
- The government has set aside about 500 billion INR to inoculate the world’s most populous country after China.
- Modi on Tuesday said his government will ensure all Indians have easy access to a Covid-19 vaccine as soon it is ready for inoculation purposes.
- Earlier Adar Poonawalla, head of Serum Institute of India stated that the subcontinent would require roughly 800 billion rupees to procure and vaccinate citizens residing everywhere from the Himalayas to the remote Andaman & Nicobar Islands.
PM Narendra Modi’s government approximates an aggregate cost of about $6-$7 per person in the country of 1.3 billion, The money provisioned so far is for the current financial year ending March 31 and there will be no shortage of further funds for this purpose, as per the disclosure of people familiar with the decision.The government has set aside about 500 billion INR to inoculate the world’s most populous country after China against the coronavirus, according to people with knowledge of the information.Modi on Tuesday said his government will ensure all Indians have easy access to a Covid-19 vaccine as soon it is ready for inoculation purposes.
Ramanan Laxminarayan, director of the Center for Disease Dynamics, Economics & Policy said,
“I doubt that the marginal cost of a vaccine would be anything close to that number at the volumes that India will purchase.
There’s one large buyer – India — and one large seller, potentially.
He added,
“A lot will come down to negotiations and the government has a lot more power in these situations.” Earlier Adar Poonawalla, head of Serum Institute of India, stated that the subcontinent would require roughly 800 billion rupees to procure and vaccinate citizens residing everywhere from the Himalayas to the remote Andaman & Nicobar Islands. Apart from buying the treatment, transporting them from manufacturing sites would be a big endeavour. By one estimation, airlifting single-dose systematic plans to protect the world’s population would require space in about 8,000 cargo planes.
Kiran Mazumdar-Shaw, the founder, and chairman of Biocon Ltd.,at the Bloomberg India Economic Forum last week pointed out that a massive challenge for India will be constructing cold-chain logistics to distribute vaccines across India in a short period of time.
She said,
“I do hope by the end of November that we are able to say we have a plan” and digital platforms to help roll out vaccines.
